Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 1021–1035 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5786
TJP1 Deficiency Test

This test evaluates the TJP1 gene for pathogenic variants associated with TJP1 deficiency using Next-Generation Sequencing (NGS). It identifies single-nucleotide variants, small in...

Whole blood (EDTA) or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TJP1 gene sequence", "Pathogenic variants in TJP1"]
Parameters
[]
Preparation
["No special preparation such as fasting is required.", "Continue all regular medications unless advised otherwise by your doctor."]
Indications
["Suspected TJP1 deficiency", "Diagnosis of metabolic disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103204-5 ICD-10: E88.89
Clinical summary
This test evaluates the TJP1 gene for pathogenic variants associated with TJP1 deficiency using Next-Generation Sequencing (NGS). It identifies single-nucleotide variants, small insertions/deletions, and copy-number alterations.
TEST-4662
TMEM216 Gene Joubert Syndrome Type 2 Genetic Test

This genetic test identifies pathogenic variants in the TMEM216 gene, which are associated with Joubert syndrome type 2, a rare neurodevelopmental disorder.

Peripheral whole blood (venous draw) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TMEM216 gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number changes"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Suspected Joubert syndrome type 2", "Family history of ciliopathies", "Carrier screening", "Prenatal testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Q04.3
Clinical summary
This genetic test identifies pathogenic variants in the TMEM216 gene, which are associated with Joubert syndrome type 2, a rare neurodevelopmental disorder.
TEST-4705
TMEM38B Gene Osteogenesis Imperfecta Type 14 Genetic Test

This test evaluates the TMEM38B gene for mutations associated with Osteogenesis Imperfecta type 14.

Peripheral Whole Blood (DNA-stabilizing tube) 3–4 Weeks (expedited available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["TMEM38B gene sequence", "Pathogenic variants (point mutations, small insertions/deletions, copy number variants)"]
Parameters
[]
Preparation
["No fasting required", "No medication cessation required", "Inform physician of all supplements and medications"]
Indications
["Suspected diagnosis of Osteogenesis Imperfecta type 14", "Genetic counselling for families with bone fragility disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21643-8 ICD-10: Q78.0
Clinical summary
This test evaluates the TMEM38B gene for mutations associated with Osteogenesis Imperfecta type 14.
TEST-4122
TMEM67 Gene COACH Syndrome Genetic Test

This test evaluates the TMEM67 gene for mutations associated with COACH syndrome.

Whole Blood (EDTA), Extracted DNA, or DNA FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TMEM67 gene sequence", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications without physician consultation"]
Indications
["Clinical suspicion of Joubert spectrum disorders", "Patients with features of COACH syndrome", "Carrier screening for at-risk family members", "Confirmatory diagnosis when neuroimaging shows 'molar tooth sign'"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21759-9 ICD-10: Q04.3
Clinical summary
This test evaluates the TMEM67 gene for mutations associated with COACH syndrome.
TEST-4598
TMEM67 Gene Joubert Syndrome Type 6 Genetic Test

This test analyzes the TMEM67 gene for variants associated with Joubert syndrome type 6, a rare neurodevelopmental disorder.

Whole Blood (EDTA) or Saliva 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TMEM67 gene sequence", "Pathogenic variants in TMEM67"]
Parameters
[]
Preparation
["No fasting required", "No special preparation needed"]
Indications
["Suspected Joubert syndrome type 6", "Neurodevelopmental delay with characteristic features", "Family history of JBTS6"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21663-5 ICD-10: Q04.3
Clinical summary
This test analyzes the TMEM67 gene for variants associated with Joubert syndrome type 6, a rare neurodevelopmental disorder.
TEST-4600
TNFAIP3 Gene (Rheumatoid Arthritis Susceptibility) Next‑Generation Sequencing DNA Test

This test evaluates the TNFAIP3 gene for variants associated with increased susceptibility to rheumatoid arthritis and related autoimmune disorders.

Whole Blood (EDTA), Extracted DNA, or FTA Card 21–28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["TNFAIP3 gene variants", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid recent blood transfusion (less than 2 weeks)"]
Indications
["Assessment of genetic predisposition to rheumatoid arthritis", "Prognostic stratification in RA patients", "Guiding therapeutic decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 69787-6 ICD-10: M05.9, L40.59, Z15.09
Clinical summary
This test evaluates the TNFAIP3 gene for variants associated with increased susceptibility to rheumatoid arthritis and related autoimmune disorders.
TEST-4940
TNFRSF13B Gene Common Variable Immunodeficiency Type 2 Genetic Test

This genetic test identifies pathogenic variants in the TNFRSF13B gene associated with Common Variable Immunodeficiency Type 2 (CVID2).

Blood / DNA / FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TNFRSF13B gene"]
Parameters
[]
Preparation
["No fasting required", "Mandatory genetic counseling session before collection", "Parental/guardian consent required for patients under 18"]
Indications
["Suspected Common Variable Immunodeficiency Type 2 (CVID2)", "Family history of CVID2", "Recurrent infections with low immunoglobulin levels"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 69568-0 ICD-10: D83.8, L98.8, Z13.0
Clinical summary
This genetic test identifies pathogenic variants in the TNFRSF13B gene associated with Common Variable Immunodeficiency Type 2 (CVID2).
TEST-4676
TNFSF11 Gene Osteopetrosis, Autosomal Recessive Type 2 Genetic Test

This genetic test identifies pathogenic variants in the TNFSF11 gene associated with autosomal recessive osteopetrosis type 2.

Whole Blood (EDTA), Extracted DNA (TE buffer), Dried Blood Spot (FTA Card) 15–20 business days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TNFSF11 gene", "Coding exons and splice junctions of TNFSF11"]
Parameters
[]
Preparation
["No special preparation or fasting is required."]
Indications
["Suspected autosomal recessive osteopetrosis type 2", "Evaluation for hematopoietic stem cell transplantation eligibility"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88515-7 ICD-10: Q78.2
Clinical summary
This genetic test identifies pathogenic variants in the TNFSF11 gene associated with autosomal recessive osteopetrosis type 2.
TEST-3301
Topiramate Test

This diagnostic test evaluates the concentration of topiramate in a patient's serum or plasma.

Serum or Plasma 3–5 business days 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Topiramate Concentration"]
Parameters
[{"name": "Topiramate", "reference_range": "5–20 mg/L"}]
Preparation
["Draw blood at peak (2–4 hours post-dose) or trough (0.5–1 hour pre-dose) at steady state.", "Note exact timing and dose.", "No fasting required.", "Use a plain red-top tube (no serum separator gel)."]
Indications
["Dose individualization for epilepsy", "Dose individualization for migraine prevention", "Monitoring therapeutic levels", "Assessing compliance", "Evaluating potential toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10375-9 ICD-10: G40.9
Clinical summary
This diagnostic test evaluates the concentration of topiramate in a patient's serum or plasma.
TEST-1076
Total Estrogen Serum Test

This diagnostic test evaluates the total levels of estrogenic hormones (E1, E2, E3) in the serum.

Serum 2–3 weeks 2,500.00 AED
View
View test specifications and preparation
What it measures
["Total oestrogens (E1, E2, E3)", "Ovarian function"]
Parameters
[{"name": "Total oestrogens (E1, E2, E3)", "reference_range": null}]
Preparation
["No fasting required", "Inform phlebotomist of all medications and hormonal supplements"]
Indications
["Evaluation of ovarian function", "Monitoring hormone therapy", "Investigation of menstrual irregularities", "Investigation of infertility", "Investigation of menopausal transition"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 2243-1 ICD-10: E28.9, E34.9, Z13.29
Clinical summary
This diagnostic test evaluates the total levels of estrogenic hormones (E1, E2, E3) in the serum.
TEST-3111
TP63 Gene (Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate) Genetic Test

This genetic test detects pathogenic variants in the TP63 gene associated with Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in TP63 gene", "Coding exons and splice junctions"]
Parameters
[]
Preparation
["A genetic counselling session and a detailed three-generation pedigree chart must be completed before sample collection."]
Indications
["Suspected diagnosis of AEC syndrome", "Family history of AEC syndrome", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81320-2 ICD-10: Q87.0
Clinical summary
This genetic test detects pathogenic variants in the TP63 gene associated with Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome.
TEST-3270
TPI1 Gene Hemolytic Anemia due to Triosephosphate Isomerase Deficiency Genetic Test

This genetic test identifies mutations in the TPI1 gene associated with triosephosphate isomerase deficiency, a cause of hemolytic anemia and neurological issues.

Whole blood, extracted DNA, or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TPI1 gene", "SNVs, indels, CNVs"]
Parameters
[]
Preparation
["Genetic counselling is mandatory before sample collection"]
Indications
["Definitive diagnosis of triosephosphate isomerase deficiency", "Carrier detection", "Prenatal planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: D55.2
Clinical summary
This genetic test identifies mutations in the TPI1 gene associated with triosephosphate isomerase deficiency, a cause of hemolytic anemia and neurological issues.
TEST-5847
TPK1 Gene Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5) Genetic Test

This genetic test identifies pathogenic variants in the TPK1 gene associated with Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5). It utilizes next-generation sequencing to...

Whole Blood, Extracted DNA, or FTA Card Blood Spot 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TPK1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No medication changes required"]
Indications
["Suspected Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5)", "Family history of THMD5", "Neurological symptoms suggestive of a neurometabolic disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94473-7 ICD-10: E53.8
Clinical summary
This genetic test identifies pathogenic variants in the TPK1 gene associated with Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5). It utilizes next-generation sequencing to analyze the entire coding region of the gene.
TEST-6080
TPP1 Gene (Neuronal Ceroid Lipofuscinosis Type 2) Genetic Test

This test analyzes the TPP1 gene for mutations associated with Neuronal Ceroid Lipofuscinosis Type 2 (CLN2 disease). It identifies pathogenic variants, deletions, or duplications w...

Peripheral Whole Blood or FTA Card (Dried Blood Spot) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TPP1 gene", "Copy Number Variations (CNV) in the TPP1 gene"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the lab about any recent blood transfusions or stem cell transplants."]
Indications
["Suspected diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 (CLN2 disease)", "Carrier screening in individuals with family history", "Family planning for individuals at risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 97746-5 ICD-10: E75.4
Clinical summary
This test analyzes the TPP1 gene for mutations associated with Neuronal Ceroid Lipofuscinosis Type 2 (CLN2 disease). It identifies pathogenic variants, deletions, or duplications within the gene.
TEST-3311
Trazodone Therapeutic Drug Monitoring Test

This test measures the concentration of trazodone in the blood to help optimize dosage and monitor for potential toxicity.

Serum 2–3 weeks (after monthly batch cutoff) 1,500.00 AED
View
View test specifications and preparation
What it measures
["Serum Trazodone Concentration"]
Parameters
[{"name": "Trazodone", "reference_range": "0.5–2.5 mg/L (therapeutic window)"}]
Preparation
["Inform doctor of all medications", "No special fasting required"]
Indications
["Initiating trazodone therapy", "After dose changes", "Appearance of adverse effects", "Suspected non-adherence"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 35729-1 ICD-10: Z51.81
Clinical summary
This test measures the concentration of trazodone in the blood to help optimize dosage and monitor for potential toxicity.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area